Stockholders’ Deficit (Details Narrative) - Sonnet BioTherapeutics Holdings, Inc. [Member] - USD ($)
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
Dec. 10, 2024 |
Nov. 07, 2024 |
Sep. 30, 2024 |
Jun. 21, 2024 |
Jun. 19, 2024 |
May 02, 2024 |
Oct. 26, 2023 |
Jun. 30, 2023 |
Feb. 10, 2023 |
Aug. 15, 2022 |
Jun. 30, 2024 |
Oct. 31, 2023 |
Jun. 30, 2023 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Jun. 30, 2024 |
Dec. 31, 2023 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Dec. 30, 2023 |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing costs incurred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 465,200
|
$ 157,500
|
$ 370,426
|
|
|
Proceeds from sale of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,803,453
|
$ 3,899,157
|
$ 3,896,577
|
21,006,371
|
|
Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
187,500
|
|
|
|
|
|
187,500
|
|
|
187,500
|
|
|
|
Warrant, shares |
|
|
1,265,972
|
|
|
|
|
|
|
|
|
|
|
5,789,600
|
|
|
|
|
5,789,600
|
|
1,265,972
|
|
|
Proceeds from warrant exercises |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,983,769
|
849
|
|
Proceeds from offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,500,000
|
|
|
|
|
Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, net of issuance costs, shares |
|
|
|
|
|
|
|
20,795
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
|
|
|
|
|
28,409
|
|
|
|
|
28,409
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
$ 79.20
|
|
|
|
|
$ 79.20
|
|
|
|
|
|
|
|
|
|
|
Gross proceeds from private placement |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,300,000
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of private placement |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,900,000
|
|
|
|
|
|
|
|
|
|
|
Common Stock Warrants October 2023 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
$ 9.6000
|
|
|
|
|
|
|
|
|
|
|
$ 9.6000
|
|
|
|
|
$ 9.6000
|
|
$ 9.6000
|
|
|
Warrant exercise price decrease |
|
|
|
|
|
|
|
|
|
|
$ 9.60
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant, shares |
|
|
354,994
|
|
|
|
|
|
|
|
|
|
|
354,994
|
|
|
|
|
354,994
|
|
354,994
|
|
|
Expiration date |
|
|
Oct. 27, 2028
|
|
|
|
|
|
|
|
|
|
|
Oct. 27, 2028
|
|
|
|
|
Oct. 27, 2028
|
|
Oct. 27, 2028
|
|
|
October Offering [Member] | Underwriters [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock |
|
|
|
|
|
|
$ 3,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
|
|
|
|
10,664
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
$ 16.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Public Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds |
|
|
|
|
|
|
|
|
$ 15,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock |
|
|
|
|
|
|
|
|
$ 13,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registered Direct Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share |
$ 2.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from offering |
$ 3,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registered Direct Offering [Member] | Prefunded Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share |
$ 2.2299
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share |
$ 2.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of share, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10
|
$ 105
|
|
$ 16
|
|
|
$ 17
|
$ 10
|
|
Sale of common stock, net of issuance costs, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98,846
|
1,050,500
|
|
163,281
|
|
|
167,987
|
104,159
|
|
Net share settlement of warrants, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,209
|
92,493
|
1,795
|
|
|
94,288
|
64,928
|
|
Shares released from abeyance, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 16
|
|
$ 3
|
|
|
|
|
|
|
|
Common Stock [Member] | October Offering [Member] | Underwriters [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares for sale |
|
|
|
|
|
|
163,281
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] | Public Offering [Member] | Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, net of issuance costs, shares |
|
|
|
|
|
|
|
|
66,277
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prefunded Warrant [Member] | October Offering [Member] | Underwriters [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
|
|
|
|
192,187
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share |
|
|
|
|
|
|
$ 12.7992
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
$ 0.0008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prefunded Warrant [Member] | Public Offering [Member] | Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
|
|
|
|
|
|
12,636
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share |
|
|
|
|
|
|
|
|
$ 190.0624
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
$ 0.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prefunded Warrant [Member] | Registered Direct Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares for sale |
768,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
317,325
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prefunded Warrant [Member] | Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares for sale |
127,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
545,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Warrant [Member] | October Offering [Member] | Underwriters [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
|
|
|
|
710,931
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share |
|
|
|
|
|
|
$ 12.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
$ 12.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Warrant [Member] | Public Offering [Member] | Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
|
|
|
|
|
|
157,818
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share |
|
|
|
|
|
|
|
|
$ 190.08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
$ 190.08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, net of issuance costs, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,209
|
94,288
|
94,288
|
64,928
|
|
Warrant, shares |
|
|
187,500
|
|
|
|
|
|
|
|
187,500
|
|
|
|
|
|
187,500
|
|
|
187,500
|
187,500
|
|
|
Net share settlement of warrants, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,419
|
96,090
|
96,090
|
126,583
|
|
Number of warrant exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
355,937
|
355,937
|
17,249
|
|
Proceeds from warrant exercises |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,000,000.0
|
$ 3,000,000.0
|
|
|
Number of warrant expired |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33
|
|
Common Stock Warrants [Member] | Holder [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited warrants, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,302
|
4,302
|
|
|
June 2024 Inducement Offer [Member] | October Offering [Member] | Underwriters [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price decrease |
|
|
|
|
|
|
$ 9.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant [Member] | Registered Direct Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
1,085,325
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
$ 2.10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants term |
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant [Member] | Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
673,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
$ 2.10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants term |
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrant exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,273,436
|
|
|
|
|
Purchase and Registration Rights Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock avialable to be sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 24,700,000
|
|
|
|
|
$ 24,700,000
|
|
|
|
|
Purchase and Registration Rights Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of share, value |
|
|
|
|
|
$ 25,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, net of issuance costs, shares |
|
|
|
|
|
77,771
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of stock, percentage |
|
|
|
|
|
19.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 200,000
|
|
$ 100,000
|
|
|
Volume weighted average price discount percentage |
|
|
|
|
|
4.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
153,020
|
|
4,706
|
|
|
Purchase and Registration Rights Agreement [Member] | Common Stock [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds |
|
|
$ 25,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing costs incurred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
$ 400,000
|
|
|
2022 Sales Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of share, value |
|
|
|
|
|
|
|
|
|
$ 7,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 Sales Agreement [Member] | BTIG LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of share, value |
|
|
|
|
|
|
|
|
|
$ 25,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,700,000
|
|
Shares for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,087
|
|
Proceeds from sale of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,500,000
|
|
2022 Sales Agreement [Member] | Underwriter Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
|
|
|
|
|
|
5,523
|
|
|
|
|
|
|
|
|
|
|
|
|
852
|
|
Exercise price |
|
|
|
|
|
|
|
|
$ 237.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 118.78
|
Warrants term |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 Sales Agreement [Member] | Prefunded Warrant [Member] | Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
|
|
|
|
|
7,613
|
|
|
|
|
7,613
|
|
|
|
|
|
|
|
|
|
|
2022 Sales Agreement [Member] | Common Warrant [Member] | Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.02
|
$ 118.78
|
Warrant exercise price decrease |
|
|
|
|
|
|
|
|
|
|
$ 12.40
|
|
|
|
|
|
|
|
|
|
|
|
|
Inducement Offer Letter Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
$ 12.80
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price decrease |
|
|
|
|
|
|
|
|
|
|
|
$ 9.60
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
353,562
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of warrants |
|
|
|
$ 2,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant, shares |
|
|
187,500
|
|
|
|
|
|
|
|
|
|
|
187,500
|
|
|
|
|
187,500
|
|
187,500
|
|
|
Shares released from abeyance, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 187,500
|
|
|
|
|
Inducement Offer Letter Agreements [Member] | Placement Agent [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
|
|
14,142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
$ 14.88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inducement Offer Letter Agreements [Member] | New Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant, shares |
|
|
|
|
703,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inducement Offer Letter Agreements [Member] | Existing Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
$ 12.80
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price decrease |
|
|
|
|
$ 9.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant, shares |
|
|
|
|
354.994
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inducement Offer Letter Agreements [Member] | Existing Warrant Issued in June 2023 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant, shares |
|
|
|
|
|
|
|
28,409
|
|
|
|
|
28,409
|
|
|
|
|
|
|
|
|
|
|
Inducement Offer Letter Agreements [Member] | Existing Warrant Issued in June 2023 [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
$ 118.78
|
|
|
|
|
$ 118.78
|
|
|
|
|
|
|
|
|
|
|
Expiration date |
|
|
|
|
|
|
|
Jun. 21, 2029
|
|
|
|
|
Jun. 21, 2029
|
|
|
|
|
|
|
|
|
|
|
Inducement Offer Letter Agreements [Member] | Existing Warrant Issued in June 2023 [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
$ 12.40
|
|
|
|
|
$ 12.40
|
|
|
|
|
|
|
|
|
|
|
Expiration date |
|
|
|
|
|
|
|
Dec. 30, 2026
|
|
|
|
|
Dec. 30, 2026
|
|
|
|
|
|
|
|
|
|
|
Inducement Offer Letter Agreements [Member] | New Common Stock Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
$ 12.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriting Agreement [Member] | Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares for sale |
|
155,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from offering |
|
$ 4,200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriting Agreement [Member] | Prefunded Warrant [Member] | Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
956,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share |
|
$ 4.4999
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriting Agreement [Member] | Common Warrant [Member] | Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
2,222,222
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share |
|
$ 4.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
$ 4.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants term |
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|